RxDoctor Payments Data

Edward Ball, DO

Family Medicine · Grand Ledge, MINPI 1750499083

Payments from drug & device makers

$1,204in general payments, 2019–2025

Across 112 payments — averaging $10.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$607
  • AbbVie$180
  • Pfizer$106
  • Johnson & Johnson$61
  • Exact Sciences$40
  • Amarin Pharma, Inc.$38
  • plus $172 from 9 others

What the payments were for

  • Food & beverage$1,204100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,204 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$43,143
Medicare patients
106
Services billed
619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban63$66,220
MounjaroTirzepatide40$41,569
XareltoRivaroxaban28$39,652
JanuviaSitagliptin Phosphate31$30,271
JardianceEmpagliflozin19$27,817
FarxigaDapagliflozin Propanediol20$18,844
MyrbetriqMirabegron21$17,557
OzempicSemaglutide17$17,463
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$5,770
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$5,706
Atorvastatin Calcium243$4,094
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen262$3,754
Levothyroxine Sodium305$3,529
LantusInsulin Glargine,hum.Rec.Anlog14$2,848
Pantoprazole Sodium118$2,751

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$106$66,22063 claims
Johnson & JohnsonXarelto$61$39,65228 claims
Boehringer IngelheimJardiance, Stiolto Respimat$12$33,52331 claims
MerckJanuvia$22$30,27131 claims
Astellas Pharma US IncMyrbetriq$19$17,55721 claims
Novo NordiskOzempic$607$17,46317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Grand Ledge

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →